The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial



Wiviott, Stephen D, Raz, Itamar, Bonaca, Marc P, Mosenzon, Ofri, Kato, Eri T, Cahn, Avivit, Silverman, Michael G, Bansilal, Sameer, Bhatt, Deepak L, Leiter, Lawrence A
et al (show 6 more authors) (2018) The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial. AMERICAN HEART JOURNAL, 200. 83 - 89.

[img] Text
DECLARE_Design_Paper_Re Submission - 12-7-17 CLEAN.docx - Accepted Version

Download (344kB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 20 Jul 2018 10:19
Last Modified: 16 Sep 2022 04:11
DOI: 10.1016/j.ahj.2018.01.012
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3023982